STIMALIA
Minimally invasive, battery‑free percutaneous bioelectronic implant that wirelessly delivers sustained, adjustable inhibition of pathological sympathetic hyperactivity to treat PTSD.
Targets adults with refractory PTSD (with potential extension to chronic pain and autonomic dysfunction), providing continuous, reversible neuromodulation without leads or systemic drug side effects.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A